SourcingLink.net announced that it will harness the power of pharmacogenomics in its oncology therapy development and clinical trials. Pharmacogenomics studies how the genome influence response to a drug. Dr. Mahant, a SAB member, stated that pharmacogenomics is a "powerful tool" in drug development and clinical trials because pharmacogenomics will allow drug target identification, patient stratification, it will reduce adverse side effects, allow optimal dosing, it will reduce the cost and drug development time, the data will help in any requirements for regulatory submissions and labeling of the drug, and, of course, it will help to "personalize" the drug therapy.